je.st
news
Tag: pharmaceuticals
Magee Thomson Investment Partners LLC Has $8,800,000 Stake in Alexion Pharmaceuticals, Inc.
2016-02-20 02:52:10| Biotech - Topix.net
Magee Thomson Investment Partners LLC boosted its position in Alexion Pharmaceuticals, Inc. by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,130 shares of the biopharmaceutical company's stock after buying an additional 540 shares during the period.
Tags: inc
partners
llc
investment
Ligand Pharmaceuticals Inc. to Post Q1 2016 Earnings of $0.46 Per...
2016-02-16 05:34:10| Biotech - Topix.net
Ligand Pharmaceuticals Inc. - Equities research analysts at Craig Hallum upped their Q1 2016 earnings estimates for shares of Ligand Pharmaceuticals in a research report issued to clients and investors on Thursday, according to Zacks Investment Research . Craig Hallum analyst M. Tiampo now anticipates that the brokerage will post earnings of $0.46 per share for the quarter, up from their prior forecast of $0.44.
Tags: per
post
earnings
pharmaceuticals
RXi Pharmaceuticals Corp (RXII) Upgraded to "Buy" at Zacks Investment Research
2016-02-08 01:00:49| Biotech - Topix.net
The brokerage currently has a $0.25 price target on the biotechnology company's stock. Zacks Investment Research 's price objective would indicate a potential downside of 13.67% from the company's current price.
Tags: buy
research
investment
corp
Enanta Pharmaceuticals To Present At The LEERINK Partners 5th Annual Global Healthcare Conference
2016-02-03 01:48:05| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, recently announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat format, or question and answer session with investors, at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016 at 9:15 a.m. ET
Tags: present
global
partners
annual
Synergy Pharmaceuticals Files New Drug Application For Plecanatide In Chronic Idiopathic Constipation
2016-02-03 01:28:06| drugdiscoveryonline News Articles
Synergy Pharmaceuticals Inc. recently announced the company has filed with the U.S. Food and Drug Administration (FDA) its first new drug application (NDA) for plecanatide in chronic idiopathic constipation (CIC)
Tags: application
files
drug
chronic
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »